Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat

Lawitz, EJ; Bhandari, BR; Ruane, PJ; Kohli, A; Harting, E; Ding, D; Chuang, JC; Huss, RS; Chung, C; Myers, RP; Loomba, R

Loomba, R (通讯作者),9500 Gilman Dr,ACTRI Bldg,1W202, La Jolla, CA 92093 USA.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023; 21 (1): 143

Abstract

BACKGROUND & AIMS: Patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH) are at high risk of morbidity and mortality. We prev......

Full Text Link